Progress towards a clinically-successful ATR inhibitor for cancer therapy
Yes === The DNA damage response (DDR) is now known to play an important role in both cancer development and its treatment. Targeting proteins such as ATR (Ataxia telangiectasia mutated and Rad3-related) kinase, a major regulator of DDR, has demonstrated significant therapeutic potential in cancer tr...
| Main Authors: | , , |
|---|---|
| Language: | en |
| Published: |
2021
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10454/18345 |